SRS Capital Advisors »

Summit Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $350k 24k 14.57
2026-03-31 $2.0k 105 18.89
2025-12-31 $1.6k 94 17.49
2025-09-30 $2.2k 106 20.66
2024-12-31 $14k 797 17.85
2024-09-30 $22k 1.0k 21.90
2024-06-30 $7.9k 1.0k 7.80